Overview

Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

The primary objective of the study is to investigate the ratios of p-hydroxyatorvastatin to atorvastatin in patients receiving atorvastatin treatment, who experience muscle adverse events, to elucidate whether differences in this ratio might have a positive or negative predictive value in diagnosing atorvastatin muscle toxicity.

Phase:

Phase 4

Details

Lead Sponsor:

University of Oslo School of Pharmacy

Treatments:

Atorvastatin
Atorvastatin Calcium